Clarify Pharma is likely to be one of the next in line to float on the Access segment of the Aquis Stock Exchange. It has directors and investors in common with NFT Investments (LON: NFT) and Dispersion Holdings.
The stated strategy of Clarify Pharma is investing in alternative therapies and sciences. The focus is psychedelic medicine companies with clear paths to revenues. This could include clinics, biopharma companies and medical technology businesses.
There is already a website up and running (www.clarifypharma.com) and it has details of advisers and share capital ready for the Aquis quotation. The corporate adviser is First Sentinel – just like NFT Investments and Dispersion Holdings.
So far, Clarify Pharma has raised £100,000 at 0.1p a share and £962,750 at 1p a share durin…